SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending downwards due to a recently announced $1.5 billion stock offering, which investors fear will dilute the stock's value; the offering's purpose is to enhance the company's capital position and fund future growth. While some investors view this as a buying opportunity and trust in management's vision, others are concerned about the timing and lack of clear communication regarding the use of proceeds, especially with a potential S&P 500 inclusion decision looming.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

SNSE is trending due to a potential short squeeze, fueled by its low float and recent breakout above a key price level. Community chatter highlights the stock's parabolic breakout and potential for significant gains, drawing comparisons to other stocks with similar setups. Some are also mentioning data.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to a potential short squeeze, with the community actively discussing its low float and comparing it to other stocks that have experienced similar rapid gains. Bullish sentiment is fueled by the high cost to borrow shares and speculation about the company's technology and future prospects. Traders are also highlighting potential sympathy plays.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies ($QCLS) is trending due to investor Martin Shkreli taking a position and setting a bold price target, sparking community discussion around a potential short squeeze. Comparisons to $SMX are being made, with traders actively watching for multi-day runner potential within the photonics sector. Bullish sentiment is growing as traders evaluate if $QCLS can reach similar gains.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending as traders draw comparisons to other Hong Kong-based stocks, like SMX, that have recently seen significant gains, focusing on SUGP's low float and potential for a short squeeze. Community chatter highlights the company's expansion into EV infrastructure and AI, adding to the positive sentiment. Some are taking profits from SMX and rotating into SUGP.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is trending due to a mixed reaction to earnings and the CFO's departure, with community members debating whether the dip presents a buying opportunity or reflects deeper issues. Despite beating EPS and revenue estimates and achieving positive cash flow, some investors are concerned about lowered guidance and competition in the cybersecurity space, while others see the stock as undervalued relative to peers like Crowdstrike. Discussions also include speculation about a potential company sale or acquisition.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending due to a recently announced $1.5 billion stock offering, which has sparked debate among investors about dilution and the company's future prospects. While some view this as a strategic move to fund upcoming factory construction, others express concerns about the company's current valuation and lack of revenue. The community is actively discussing the potential impact of the offering on the stock price and whether it presents a buying opportunity or a sign of an overvalued company.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is trending as investors digest recent earnings and a subsequent price dip, with many viewing the pullback as a buying opportunity. Community members are discussing the company's growth prospects in AI-driven data security and resilience, particularly following a partnership announcement. Despite some concerns about valuation and competition, bulls are emphasizing long-term potential and key support levels.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign is trending amid discussions about its competitive positioning in the face of emerging AI technologies like OpenAI's DocuGPT, leading to both bullish and bearish sentiments. While some investors view the dip as a buying opportunity due to the company's strong fundamentals and potential AI integrations, others are concerned about commoditization and potential disruption to DocuSign's core business. Community members are actively debating DocuSign's long-term strategy and ability to maintain market share in the evolving landscape.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Global X Dow 30 Covered Call ETF ($DJIA) is trending amid discussions around market apexes and potential 'wild moves'. Traders are actively weighing bullish calls against broader market indices like $SPX and $QQQ. There's also some community interest in actionable trades, including call options with distant expiry dates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MAXHEALTH.NSE  
बहतर सेहत, बेहतरीन निवेश—MAXHEALTH शेयर के साथ सुरक्षित भविष्य की ओर बढ़ें।﻿ 
 
Technical View — Daily Chart 
$Max Healthcare formed a wide-range bullish reversal candle today after opening at ₹1,107.90, making an intraday low of ₹1,101.80 and a high of ₹1,148.10 before closing at ₹1,143.20, which signals strong intraday buying and short-covering. 
$Price is now holding above the 14 day EMA and the ₹1,135 horizontal support, with RSI rebounding from sub 50 toward the mid 50s and daily MACD histogram flattening (still negative), suggesting a short term mean reversion attempt rather than a confirmed trend reversal. 
Key intraday/near term levels: support ₹1,135 (14 day EMA) and ₹1,120 (stopwatch support); immediate resistance ₹1,190–₹1,200 and higher resistance cluster near the 50 DMA around ₹1,240–1,260. 
 
Volume/structure note: Today’s $range expansion on higher volumes relative to the prior down days supports the probability of a follow through; look for sustained volume above the 10 day average to validate continuation. 
 
Trade plan (actionable) 
Short term trading (speculative): Buy on dips ₹1,135–1,140; Stop loss ₹1,120; Targets ₹1,190 (first) and ₹1,200 (stretch). Scale out 50% at first target. 
Intraday setup: Long above intraday high ₹1,148 on momentum with tight trailing stop below the 14 EMA. 
Positional/Investors: Prefer staggered accumulation (SIP style) or wait for consolidation above ₹1,200 to reduce valuation risk. 
 
Short / Medium / Long term technical bias 
Short term (days–weeks): Constructive if ₹1,135 holds; expect 1,190–1,200 in a follow through scenario. 
Medium term (weeks–months): Neutral to cautious; stock still below longer moving averages, needs a higher high and higher low confirmation. 
Long term (12+ months): Positive business case but technical confirmation required — watch monthly close relative to the 50  and 100 month smoothing for structural turn. 
 
Upcoming News / Events &amp; Likely Impact 
•CGHS Rate Revision: Government revised CGHS package rates across ~2,000 procedures (effective mid October window), boosting realization outlook for hospital chains handling CGHS cases; market reacted positively to this sectoral tailwind and it is a near term revenue/margin catalyst. 
•Earnings / Board dates: Monitor next quarterly updates and management commentary on occupancy, ARPOB, and guidance — any upside surprise can trigger strong moves; a miss may cause sharp re-rating because of current high multiples. 
•Other events to watch: policy updates on insurance reimbursements, NABH/NABL accreditations, and major tie-ups with insurers or govt schemes which can affect volumes and collections. 
 
Disclosure &amp; Disclaimer 
This note is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Market and stock prices may be volatile; investors should perform their own due diligence or consult a registered financial adviser before taking any position. Past performance is not an indicator of future returns. Data and news references are taken from public sources and brokerage reports (news articles and company filings) available as of the date of this note. No position in Max Healthcare is held at the time of writing.

Bala Yogesh

Anubhav Mishra

StockTwits Web

Max Healthcare Institute Ltd.

MediaAlpha Inc - Ordinary Shares - Class A

  
बहतर सेहत, बेहतरीन निवेश—MAXHEALTH शेयर के साथ सुरक्षित भविष्य की ओर बढ़ें।﻿ 
 
Technical View — Daily Chart 


 Healthcare formed a wide-range bullish reversal candle today after opening at ₹1,107.90, making an intraday low of ₹1,101.80 and a high of ₹1,148.10 before closing at ₹1,143.20, which signals strong intraday buying and short-covering. 
$Price is now holding above the 14 day EMA and the ₹1,135 horizontal support, with RSI rebounding from sub 50 toward the mid 50s and daily MACD histogram flattening (still negative), suggesting a short term mean reversion attempt rather than a confirmed trend reversal. 
Key intraday/near term levels: support ₹1,135 (14 day EMA) and ₹1,120 (stopwatch support); immediate resistance ₹1,190–₹1,200 and higher resistance cluster near the 50 DMA around ₹1,240–1,260. 
 
Volume/structure note: Today’s $range expansion on higher volumes relative to the prior down days supports the probability of a follow through; look for sustained volume above the 10 day average to validate continuation. 
 
Trade plan (actionable) 
Short term trading (speculative): Buy on dips ₹1,135–1,140; Stop loss ₹1,120; Targets ₹1,190 (first) and ₹1,200 (stretch). Scale out 50% at first target. 
Intraday setup: Long above intraday high ₹1,148 on momentum with tight trailing stop below the 14 EMA. 
Positional/Investors: Prefer staggered accumulation (SIP style) or wait for consolidation above ₹1,200 to reduce valuation risk. 
 
Short / Medium / Long term technical bias 
Short term (days–weeks): Constructive if ₹1,135 holds; expect 1,190–1,200 in a follow through scenario. 
Medium term (weeks–months): Neutral to cautious; stock still below longer moving averages, needs a higher high and higher low confirmation. 
Long term (12+ months): Positive business case but technical confirmation required — watch monthly close relative to the 50  and 100 month smoothing for structural turn. 
 
Upcoming News / Events & Likely Impact 
•CGHS Rate Revision: Government revised CGHS package rates across ~2,000 procedures (effective mid October window), boosting realization outlook for hospital chains handling CGHS cases; market reacted positively to this sectoral tailwind and it is a near term revenue/margin catalyst. 
•Earnings / Board dates: Monitor next quarterly updates and management commentary on occupancy, ARPOB, and guidance — any upside surprise can trigger strong moves; a miss may cause sharp re-rating because of current high multiples. 
•Other events to watch: policy updates on insurance reimbursements, NABH/NABL accreditations, and major tie-ups with insurers or govt schemes which can affect volumes and collections. 
 
Disclosure & Disclaimer 
This note is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Market and stock prices may be volatile; investors should perform their own due diligence or consult a registered financial adviser before taking any position. Past performance is not an indicator of future returns. Data and news references are taken from public sources and brokerage reports (news articles and company filings) available as of the date of this note. No position in Max Healthcare is held at the time of writing.

This account has been verified as a SEBI Research Analyst (RA).